These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8739293)

  • 1. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
    Sharma RK; Jha R; Kumar P; Kher V; Gupta A; Kumar A; Gulati S; Arora P; Murari M; Bhandari M
    Am J Nephrol; 1996; 16(4):358-60. PubMed ID: 8739293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials.
    Llorente S; Gimeno L; Navarro MJ; Moreno S; Rodriguez-Gironés M
    Transplantation; 2000 Sep; 70(5):800-1. PubMed ID: 11003361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
    Halim MA; Alfurayh O; Kalin ME; Dammas S; al-Eisa A; Damanhouri G
    Clin Infect Dis; 1993 Mar; 16(3):397-9. PubMed ID: 8135901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Imported visceral leishmaniasis (kala azar) in a German infant].
    Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
    Klin Padiatr; 1995; 207(6):347-9. PubMed ID: 8569138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful therapeutic splenectomy in an HIV patient with relapsing visceral leishmaniasis.
    Alon D; Chowers M
    Int J STD AIDS; 2012 Apr; 23(4):289-90. PubMed ID: 22581957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
    Roberts WL; Hariprashad J; Rainey PM; Murray HW
    Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral leishmaniasis with an unusually long incubation time].
    Matzdorff AC; Matthes K; Kemkes-Matthes B; Pralle H
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):890-4. PubMed ID: 9264920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of visceral leishmaniasis in patients with antimonials: is there a maximal dose?].
    Llorens Soriano P; Vicente Ull R; Paricio Blasco A; Cervera Juan A; Rubio Rodrigo MJ
    An Med Interna; 1999 Nov; 16(11):602. PubMed ID: 10638007
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.
    Siriwardana HVYD; Karunanayake P; Goonerathne L; Karunaweera ND
    Pathog Glob Health; 2017 Sep; 111(6):317-326. PubMed ID: 28820339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis: a difficult diagnosis and unusual causative agent.
    Oren R; Schnur LF; Ben Yehuda D; Mayner V; Okon E; Rachmilewitz EA
    J Infect Dis; 1991 Oct; 164(4):746-9. PubMed ID: 1654358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed and overlooked diagnosis of an unusual opportunistic infection in a renal transplant recipient: visceral leishmaniasis.
    Zümrütdal A; Erken E; Turunç T; Çolakoğlu Ş; Demıroğlu YZ; Özelsancak R; Solmaz S
    Turkiye Parazitol Derg; 2010; 34(4):183-5. PubMed ID: 21391189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral Leishmaniasis in children in the Yemen.
    Haidar NA; Diab AB; El-Sheik AM
    Saudi Med J; 2001 Jun; 22(6):516-9. PubMed ID: 11426243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.
    Carter KC; Baillie AJ; Mullen AB
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):61-5. PubMed ID: 9874665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of visceral leishmaniasis in Singapore.
    Abraham G; Leo YS; Singh M; Wong SY
    Ann Acad Med Singap; 1997 Sep; 26(5):713-6. PubMed ID: 9494684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
    Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
    Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
    Moulin B; Ollier J; Bouchouareb D; Purgus R; Olmer M
    Nephron; 1992; 60(3):360-2. PubMed ID: 1565190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
    Pal S; Ravindran R; Ali N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.